Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?
- PMID: 26535225
- PMCID: PMC4614339
- DOI: 10.5339/gcsp.2015.29
Genetic modifiers to the PLN L39X mutation in a patient with DCM and sustained ventricular tachycardia?
Figures
References
-
- Grimm W, Maisch B. Sudden cardiac death in dilated cardiomyopathy – therapeutic options. Herz. 2002;27(8):750–759. - PubMed
-
- Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA. Frequency and phenotypes of familial dilated cardiomyopathy. Journal of the American College of Cardiology. 1998;31(1):186–194. - PubMed
-
- Yacoub MH. Decade in review–cardiomyopathies: Cardiomyopathy on the move. Nature reviews Cardiology. 2014;11(11):628–629. - PubMed
-
- Shaw T, Elliott P, McKenna WJ. Dilated cardiomyopathy: a genetically heterogeneous disease. Lancet. 2002;360(9334):654–655. - PubMed
-
- Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW, MacLennan DH, Kranias EG. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. The Journal of biological chemistry. 2001;276(26):24145–24152. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources